26-29 SEP, 2024, ICC

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Abstracts

Abstract submissions now open

You are invited to submit an abstract to The 17th Asia Pacific Heart Rhythm Scientific Sessions (APHRS 2024).

Before preparing your abstract submission – be sure to read the below information.

Key dates

IMPORTANT DATES

Submission open: Feb 2024

Submission close: 30 April 2024

Author notifications: Late May 2024

Late breaking submission open: June 2024

Late breaking submission close: July 2024

Abstract guidelines

To assist the Program Committee in deciding if your abstract will be selected for the final sessions program, please ensure you adhere to the following guidelines:

  • The maximum character count for abstracts is 1,950 characters (NOT including spaces)
  • The abstract title is included in the overall character count
  • A maximum of 1 image can be included per abstract (JPEG format only)
  • Tables/images/graphs are included in the overall character count
  • Abstracts must be written in the English language
  • Must be written in the format: introduction, methods, results, conclusion
  • Case-based abstracts: please enter “N/A” under methods and enter your “case” under results
  • Abstracts must be submitted online using the online submission portal (emailed submissions will not be accepted)
  • Submitters can indicate a presentation preference, however this is not guaranteed
  • It is a condition of submitting that all authors disclose any commercial relationship(s)
  • The submitting author must ensure that all co-authors have approved all content details prior to submission
  • Ensure submission information is entered carefully, information will be published exactly as submitted

Abstract themes

The Asia Pacific Heart Rhythm Society offers 10 themes and 70 sub-themes. The 10 themes coincide with the specialty tracks by which The 17th Asia Pacific Heart Rhythm Scientific Sessions (APHRS 2024) are divided.

Each theme offers numerous sub-themes to which an author may submit an abstract. 

Carefully review the abstract categories and subcategories listed below before submitting an abstract.

Determine the primary category (bolded) in which you wish the abstract to be reviewed, then select only one subcategory (numbered).

01 Clinical Research
02 Teaching Case Reports

03 Stem Cell
04 Ion Channels and Transporters
05 Genomics: Bench
06 Genomics: Translational
07 Cell Signaling, Physiology & Pharmacology
08 Computer Modeling/Simulation
09 Intact Heart Electrophysiology and Pharmacology
10 Whole Animal Electrophysiology and Pharmacology (includes Neurohumoral Modulation)

Bradycardia Devices:
11 Indications
12 Device Technology
13 Clinical Trials

Tachycardia Devices:
14 Indications
15 Device Technology
16 Clinical Trials

Diagnostic Devices & Sensors:
17 Indications
18 Device Technology
19 Clinical Trials

Leads & Electrodes:
20 Implantation
21 Extraction/Removal
22 Technology
23 Clinical Trials

Monitoring & Outcomes:
24 Monitoring & Follow-up
25 Outcomes, Quality Measures & Complications

SVT/AVNRT/WPW/AT:
26 Clinical Trials/Outcomes
27 Experimental Methods
28 Quality Measures & Complications
29 Mapping & Imaging
30 Ablation

Atrial Fibrillation & Atrial Flutter:
31 Clinical Trials/Outcomes
32 Mapping & Imaging
33 Experimental methods
34 Ablation
35 Quality Measures & Complications

Ventricular Tachycardia & Ventricular Fibrillation:
36 Physiology-Pharmacology
37 Electrocardiography
38 Clinical Trials/Outcomes
39 Mapping & Imaging
40 Ablation
41 Experimental Methods
42 Quality Measures & Complications

SCA Risk Assessment:
43 Signal Processing (SAECG/TWA, HRV, QT interval)
44 Clinical Techniques
45 Other Noninvasive Techniques

Syncope & Bradycardia:
46 Physiology-Pharmacology
47 Electrocardiography
48 Clinical Trials/Outcomes
49 Experimental Methods
50 Tilt Table Testing

51 Epidemiology of Cardiac Arrhythmias/Epidemiology

52 Physiology-Pharmacology
53 Electrocardiography

Atrial Fibrillation & Atrial Flutter:
54 Physiology
55 Pharmacology (Antiarrhythmic drugs and anticoagulants)
56 Electrocardiography

Cardiac Resynchronization Therapy:
57 Indications
58 Device Technology

Non-CRT Devices for Heart Failure:
59 Autonomic Modulation
60 Other

Heart Failure Management:
61 Pharmacology
62 Clinical Trials
63 Monitoring

64 Pediatric Cardiology
65 Adult Congenital Heart Disease
66 Translational

67 Reimbursement, Regulation and Health Policy
68 Training and Education

69 Teaching Case Reports
70 Challenging EP Case Reports

Presentation types

In 2024, the following presentation types will be available. During the submission process you can indicate your presentation preference.

  • Oral presentation
  • Poster presentation

Please note that while you are able to indicate your presentation preference, this is not guaranteed and is at the discretion of the Program Committee. 

Abstract awards

During the submission process you will be able to nominate for the following awards (if eligible):

YIA competition award

Highest scoring abstract by women in EP

Highest scoring abstract by allied health professional

Best poster award

YIA Competition Award information

The Young Investigator Awards (YIA) Competition, now in its 45th year, recognises and encourages the work of young investigators and their parent institutions.

All submissions to the YIA competition will be reviewed by the YIA subcommittee (part of the APHRS 2024 Program Committee, comprised of senior researchers, clinicians, and scientists), who will select six finalists to present their work during APHRS 2024.

All interested applicants must submit their abstracts, indicate their interest, and provide supplemental materials before the APHRS 2024 abstract submission deadline.

All authors must submit an abstract through the APHRS 2024 abstract submission site.

Abstracts submitted after the advertised deadline will not be accepted. 

Please note that any abstract accepted into the YIA competition will not be presented during any other abstract session or be eligible for any other abstract award at APHRS 2024.

The YIA competition is open to any physician or scientist who is presently in a residency, fellowship, or doctoral training program, or who has been in such a program within the past three years (at the time of submission). The competition is also open to students in graduate or medical schools who are working on a problem concerned with cardiac pacing and/or electrophysiology, in the areas of clinical and basic research.

  • The applicant must be the submitting, presenting, and first author of the manuscript considered for consideration.
  • Multiple submissions from the same sponsor are discouraged.
  • Abstracts are not eligible for consideration if published prior to APHRS 2024.
  • No abstract may be presented at APHRS 2024 if it is substantially similar to material presented or to be presented at a major international meeting held prior to APHRS 2024.

Any work of an investigational nature that pertains directly or indirectly to cardiac pacing and/or electrophysiology is suitable for submission.

This work may be in basic science, clinical investigation, or technical innovations.

Finalists are selected based on:

  • Qualifications of the candidate and the originality
  • Importance and scientific excellence of a project that contributes to our understanding of cardiac pacing and electrophysiology and ultimately, improved patient care.


The Young Investigators Award competition submissions are reviewed and judged in one of two categories: basic research and clinical research.

To be considered for the YIA competition, the young investigator will need to submit an abstract during the APHRS 2024 submission period and indicate that (s)he is interested in applying for the YIA competition.

Supporting materials will be collected at the time of abstract submission.

Note: the abstract review process will generate a score of eligibility to compete in the YIA competition. If the submitted abstract does not meet minimum grade criteria, it will not be eligible for consideration in the YIA competition.

All applicants must submit the following materials at the time of their abstract submission to be considered for the YIA competition:

1. Abstract submitted during the APHRS 2024 submission period.

2. A complete manuscript of the investigation, text typed double-spaced and including all necessary tables, figures, and graphs.

Please ensure you read the manuscript guidelines

Book chapters, PhD theses, and review articles are not eligible for the YIA competition.

The manuscript must not exceed 5,000 words.

3. A brief author statement, including a description of his/her specific role in the overall study.

4. The applicant’s curriculum vitae.

5. A statement from the applicant’s sponsor or chief of service defining the role of the YIA applicant to the study.

YIA finalists will be notified via email of their acceptance the same time all abstract notifications are sent out.

Please note that APHRS 2024 will only notify the six finalists.

The first prize winner will receive a cash prize of $1,000. 

The remaining 5 finalists will receive a cash prize of $500. 

All finalists will receive an award certificate.

The results of the YIA competition will be announced in the APHRS 2024 awards ceremony. Finalists are required to attend.

Simultaneous publication opportunities

In 2024, APHRS will be offering the opportunity for you to submit an abstract for the September Scientific Sessions and at the same time indicate if you would like to be considered for simultaneous publication at one of the below journals.

You will only be able to indicate your willingness for simultaneous publication during the online abstract submission process.

Important note: Please note that if you indicate “yes” I would like to be considered for one of the below journal publications, your contact information including name and email address will be sent to the relevant journal for further communication and confirmation.

Journal of the American College of Cardiology: Clinical Electrophysiology

To find out more information about this journal and the author instructions for submission, please refer to the below details.

JACC: Clinical Electrophysiology: https://www.jacc.org/journal/electrophysiology

Author instructions: https://www.jacc.org/pb-assets/documents/author-instructions-jacc-electrophysiology-1626866000317.pdf

Circulation, Arrhythmia and Electrophysiology

To find out more information about this journal and the author instructions for submission, please refer to the below details.

Journal information: https://www.ahajournals.org/journal/circep

Author instructions: https://www.ahajournals.org/circep/author-instructions

Heart Rhythm

To find out more information about this journal and the author instructions for submission, please refer to the below details.

Journal information: https://www.hrsonline.org/publications/heart-rhythm-journal

Author instructions: https://www.sciencedirect.com/journal/heart-rhythm/publish/guide-for-authors

Europace

To find out more information about this journal and the author instructions for submission, please refer to the below details.

Journal information: https://academic.oup.com/europace

Author instructions: https://academic.oup.com/europace/pages/General_Instructions

Abstract review

  • All submitted abstracts will be peer reviewed (blind review) by the APHRS 2024 Program Committee
  • Incomplete abstracts or abstracts not written in English cannot be processed and will not be reviewed
  • No revisions to submissions are possible after the submission deadline – no exceptions 

Disclosure of commercial relationship(s)

It is the policy of The Asia Pacific Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities.

Everyone involved in the planning and participation of continuing medical education activities are required to disclose any real or apparent conflict of interest related to the content of their presentations and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationships) held within the past 12 months.

Important note: This disclosure applies to all authors listed on each submission. 

The Asia Pacific Heart Rhythm Society implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Potential disclosures are classified as below: 

A – Consulting Fees/Honoraria
B – Speaker’s Bureau
C – Equity Interests/Stock Options – Non-Public
D – Equity Interests/Stock Options – Public
E – Royalty Income
F – Non-Royalty Payments
G – Officer, Trustee, Director, Committee Chair, or Any Other Fiduciary Role
H – Ownership/Partnership/Principal
I – Research Grants
J – Fellowship Support
K – Salary
L – Intellectual Property Rights
M – Other

Alongside the above classifications, you will be required to place a monetary value to each, as per below: 

0 = $0
1 = < $10,000
2 = > $10,001 to < $25,000
3 = > $25,001 to < $50,000
4 = > $50,001 to < $100,000
5 = > $100,001

During the submission process, you will be required to either indicate there are “no disclosures” 0r enter the relevant information. 

 

 

Terms and conditions | Conditions of acceptance

All abstract submitters are required to agree to the below terms and conditions prior to submitting their work:

  • Submitting author hereby commits with the present data protection and privacy policy
  • The submitting author is the presenting author and listed as the first author.
  • All authors named in the submission have agreed to its submission for presentation
  • All authors are familiar with the data and agree with the stated results
  • All authors declare that any work with human or animal subjects related in the submission complies with the guiding principles for experimental procedures as set forth in the Declaration of Helsinki (WMA Declaration of Helsinki).
  • If accepted, the submission will be included in the supplement issue of the Journal of Arrhythmia
  • If accepted, presentation materials will be captured to assist APHRS 2024, future scientific sessions and possible on-demand content
  • If accepted, presenter is required to sign a Copyright Assignment and Audio-Visual Release Form for the purposes stated above
  • No funding is provided to accepted presenters. Accepted presenters acknowledge they must register, pay and attend the congress for their work to be included in the official program
  • All attendance expenses are bourne by the presenter

Program enquiries

Program Manager c/o MCI Australia

For all questions and enquiries about abstracts, speakers and program information.

Abstract guidelines

To assist the Program Committee in deciding if your abstract will be selected for the final sessions program, please ensure you adhere to the following guidelines:

  • The maximum character count for abstracts is 1,950 characters (NOT including spaces)
  • The abstract title is included in the overall character count
  • A maximum of 1 image can be included per abstract (JPEG format only)
  • Tables/images/graphs are included in the overall character count
  • Abstracts must be written in the English language
  • Must be written in the format: introduction, methods, results, conclusion
  • Case-based abstracts: please enter “N/A” under methods and enter your “case” under results
  • Abstracts must be submitted online using the online submission portal (emailed submissions will not be accepted)
  • Submitters can indicate a presentation preference, however this is not guaranteed
  • It is a condition of submitting that all authors disclose any commercial relationship(s)
  • The submitting author must ensure that all co-authors have approved all content details prior to submission
  • Ensure submission information is entered carefully, information will be published exactly as submitted

Abstract themes

The Asia Pacific Heart Rhythm Society offers 10 themes and 70 sub-themes. The 10 themes coincide with the specialty tracks by which The 17th Asia Pacific Heart Rhythm Scientific Sessions (APHRS 2024) are divided.

Each theme offers numerous sub-themes to which an author may submit an abstract. 

Carefully review the abstract categories and subcategories listed below before submitting an abstract.

Determine the primary category (bolded) in which you wish the abstract to be reviewed, then select only one subcategory (numbered).

01 Clinical Research
02 Teaching Case Reports

03 Stem Cell
04 Ion Channels and Transporters
05 Genomics: Bench
06 Genomics: Translational
07 Cell Signaling, Physiology & Pharmacology
08 Computer Modeling/Simulation
09 Intact Heart Electrophysiology and Pharmacology
10 Whole Animal Electrophysiology and Pharmacology (includes Neurohumoral Modulation)

Bradycardia Devices:
11 Indications
12 Device Technology
13 Clinical Trials

Tachycardia Devices:
14 Indications
15 Device Technology
16 Clinical Trials

Diagnostic Devices & Sensors:
17 Indications
18 Device Technology
19 Clinical Trials

Leads & Electrodes:
20 Implantation
21 Extraction/Removal
22 Technology
23 Clinical Trials

Monitoring & Outcomes:
24 Monitoring & Follow-up
25 Outcomes, Quality Measures & Complications

SVT/AVNRT/WPW/AT:
26 Clinical Trials/Outcomes
27 Experimental Methods
28 Quality Measures & Complications
29 Mapping & Imaging
30 Ablation

Atrial Fibrillation & Atrial Flutter:
31 Clinical Trials/Outcomes
32 Mapping & Imaging
33 Experimental methods
34 Ablation
35 Quality Measures & Complications

Ventricular Tachycardia & Ventricular Fibrillation:
36 Physiology-Pharmacology
37 Electrocardiography
38 Clinical Trials/Outcomes
39 Mapping & Imaging
40 Ablation
41 Experimental Methods
42 Quality Measures & Complications

SCA Risk Assessment:
43 Signal Processing (SAECG/TWA, HRV, QT interval)
44 Clinical Techniques
45 Other Noninvasive Techniques

Syncope & Bradycardia:
46 Physiology-Pharmacology
47 Electrocardiography
48 Clinical Trials/Outcomes
49 Experimental Methods
50 Tilt Table Testing

51 Epidemiology of Cardiac Arrhythmias/Epidemiology

52 Physiology-Pharmacology
53 Electrocardiography

Atrial Fibrillation & Atrial Flutter:
54 Physiology
55 Pharmacology (Antiarrhythmic drugs and anticoagulants)
56 Electrocardiography

Cardiac Resynchronization Therapy:
57 Indications
58 Device Technology

Non-CRT Devices for Heart Failure:
59 Autonomic Modulation
60 Other

Heart Failure Management:
61 Pharmacology
62 Clinical Trials
63 Monitoring

64 Pediatric Cardiology
65 Adult Congenital Heart Disease
66 Translational

67 Reimbursement, Regulation and Health Policy
68 Training and Education

69 Teaching Case Reports
70 Challenging EP Case Reports

Presentation types

In 2024, the following presentation types will be available. During the submission process you can indicate your presentation preference. 

  • Oral presentation
  • Poster presentation

Please note that while you are able to indicate your presentation preference, this is not guaranteed and is at the discretion of the Program Committee. 

Abstract awards

During the submission process you will be able to nominate for the following awards (if eligible):

  • YIA Competition Award
  • Highest scoring abstract by women in EP
  • Highest scoring abstract by allied health professional
  • Best poster award

YIA Competition Award information

The Young Investigator Awards (YIA) Competition, now in its 45th year, recognises and encourages the work of young investigators and their parent institutions.

All submissions to the YIA competition will be reviewed by the YIA subcommittee (part of the APHRS 2024 Program Committee, comprised of senior researchers, clinicians, and scientists), who will select six finalists to present their work during APHRS 2024.

All interested applicants must submit their abstracts, indicate their interest, and provide supplemental materials before the APHRS 2024 abstract submission deadline.

All authors must submit an abstract through the APHRS 2024 abstract submission site.

Abstracts submitted after the advertised deadline will not be accepted. 

Please note that any abstract accepted into the YIA competition will not be presented during any other abstract session or be eligible for any other abstract award at APHRS 2024.

The YIA competition is open to any physician or scientist who is presently in a residency, fellowship, or doctoral training program, or who has been in such a program within the past three years (at the time of submission). The competition is also open to students in graduate or medical schools who are working on a problem concerned with cardiac pacing and/or electrophysiology, in the areas of clinical and basic research.

  • The applicant must be the submitting, presenting, and first author of the manuscript considered for consideration.
  • Multiple submissions from the same sponsor are discouraged.
  • Abstracts are not eligible for consideration if published prior to APHRS 2024.
  • No abstract may be presented at APHRS 2024 if it is substantially similar to material presented or to be presented at a major international meeting held prior to APHRS 2024.

Any work of an investigational nature that pertains directly or indirectly to cardiac pacing and/or electrophysiology is suitable for submission.

This work may be in basic science, clinical investigation, or technical innovations.

Finalists are selected based on:

  • Qualifications of the candidate and the originality
  • Importance and scientific excellence of a project that contributes to our understanding of cardiac pacing and electrophysiology and ultimately, improved patient care.


The Young Investigators Award competition submissions are reviewed and judged in one of two categories: basic research and clinical research.

To be considered for the YIA competition, the young investigator will need to submit an abstract during the APHRS 2024 submission period and indicate that (s)he is interested in applying for the YIA competition.

Supporting materials will be collected at the time of abstract submission.

Note: the abstract review process will generate a score of eligibility to compete in the YIA competition. If the submitted abstract does not meet minimum grade criteria, it will not be eligible for consideration in the YIA competition.

All applicants must submit the following materials at the time of their abstract submission to be considered for the YIA competition:

1. Abstract submitted during the APHRS 2024 submission period.

2. A complete manuscript of the investigation, text typed double-spaced and including all necessary tables, figures, and graphs.

Please ensure you read the manuscript guidelines

Book chapters, PhD theses, and review articles are not eligible for the YIA competition.

The manuscript must not exceed 5,000 words.

3. A brief author statement, including a description of his/her specific role in the overall study.

4. The applicant’s curriculum vitae.

5. A statement from the applicant’s sponsor or chief of service defining the role of the YIA applicant to the study.

YIA finalists will be notified via email of their acceptance the same time all abstract notifications are sent out.

Please note that APHRS 2024 will only notify the six finalists.

The first prize winner will receive a cash prize of $1,000. 

The remaining 5 finalists will receive a cash prize of $500. 

All finalists will receive an award certificate.

The results of the YIA competition will be announced in the APHRS 2024 awards ceremony. Finalists are required to attend.